AGIO - AGIOS PHARMACEUTICALS, INC.
27.68
-0.510 -1.842%
Share volume: 1,020,375
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$28.19
-0.51
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 10-31-2024 | 02-13-2025 | 05-01-2025 | 07-31-2025 | 10-30-2025 | 02-12-2026 | |
| Assets | |||||||||
| Total Assets | 849.709 M | 773.063 M | 1.792 B | 1.663 B | 1.556 B | 1.471 B | 1.386 B | 1.297 B | |
| Current Assets | 663.627 M | 632.127 M | 1.074 B | 965.600 M | 968.616 M | 1.019 B | 1.033 B | 942.052 M | |
| Inventories | 23.070 M | 23.937 M | 26.429 M | 27.616 M | 29.605 M | 30.848 M | 32.034 M | 32.920 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 479.227 M | 485.374 M | 751.027 M | 817.463 M | 814.411 M | 858.066 M | 860.150 M | 765.295 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 118.764 M | 84.518 M | 253.730 M | 76.247 M | 78.964 M | 80.871 M | 92.710 M | 89.130 M | |
| Total Non-current Assets | 116.301 M | 75.404 M | 655.889 M | 638.321 M | 531.253 M | 400.467 M | 304.341 M | 310.013 M | |
| Property Plant Equipment | 14.119 M | 12.726 M | 11.819 M | 11.675 M | 11.067 M | 10.579 M | 10.675 M | 10.775 M | |
| Other Assets | 171.963 M | 128.210 M | 705.786 M | 685.924 M | 575.835 M | 441.194 M | 341.921 M | 344.398 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 849.709 M | 773.063 M | 1.792 B | 1.663 B | 1.556 B | 1.471 B | 1.386 B | 1.297 B | |
| Total liabilities | 105.787 M | 112.553 M | 165.122 M | 122.243 M | 88.990 M | 101.682 M | 101.375 M | 104.111 M | |
| Total current liabilities | 51.691 M | 62.637 M | 119.451 M | 81.156 M | 52.366 M | 70.410 M | 74.757 M | 82.206 M | |
| Accounts Payable | 11.155 M | 10.035 M | 17.143 M | 16.643 M | 13.726 M | 17.532 M | 19.553 M | 18.355 M | |
| Other liabilities | 54.096 M | 49.916 M | 45.671 M | 41.087 M | 36.624 M | 31.272 M | 26.618 M | 21.905 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 54.096 M | 49.916 M | 45.671 M | 41.087 M | 36.624 M | 31.272 M | 26.618 M | 21.905 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 743.922 M | 660.510 M | 1.627 B | 1.541 B | 1.467 B | 1.370 B | 1.284 B | 1.193 B | |
| Common stock | 2.452 B | 2.464 B | 2.478 B | 2.494 B | 2.507 B | 2.522 B | 2.538 B | 2.555 B | |
| Retained earnings | -904.198 M | -1.000 B | -52.401 M | -148.924 M | -238.213 M | -350.233 M | -453.666 M | -561.705 M |